High Vista Strategies LLC Vista Gen Therapeutics, Inc. Transaction History

High Vista Strategies LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.88 - $1.73 $277,974 - $546,472	-315,880 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$1.14 - $2.09 $297,712 - $545,805	-261,151 Reduced 45.26%	315,880 $392,000
Q4 2021 Feb 14, 2022	BUY	$1.67 - $2.76 $231,782 - $383,065	138,792 Added 31.67%	577,031 $1.13 Million
Q3 2021 Nov 15, 2021	BUY	$2.62 - $3.45 $340,974 - $448,993	130,143 Added 42.24%	438,239 $1.2 Million
Q2 2021 Aug 16, 2021	BUY	$1.96 - $3.15 $603,868 - $970,502	308,096 New	308,096 $971,000

27.1K

Ticker VTGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 206,836,000
Market Cap $527M
Description
VistaGen Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in developing and commercializing various medicines with the potential to care for anxiety, depression, and other disorders of the central nervous system (CNS). The company's CNS pipeline includes PH94B, a rapid-onset neuroactive nasal spray, which is in Phase III d...

Get notified when there are updates to the investment portfolio of High Vista Strategies LLC, based on Form 13F filings with the SEC.

Stay updated on High Vista Strategies LLC with notifications on news.